You have 9 free searches left this month | for more free features.

Lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    High-Dose Methotrexate Clearance in Diffuse Large B-Cell

    Recruiting
    • Central Nervous System Lymphoma
    • Diffuse Large B-Cell Lymphoma
    • Non-Interventional Study
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 8, 2023

    Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • GEN3017
    • (no location specified)
    Aug 25, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Diffuse Large B Cell Lymphoma
    • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Nov 19, 2023

    Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

    Not yet recruiting
    • Lymphoma, B-Cell
    • +7 more
    • Adaptive Bridging Radiation Therapy (ABRT)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 16, 2023

    Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

    Not yet recruiting
    • Primary Ocular Adnexal MALT Lymphoma
    • (no location specified)
    Sep 26, 2023

    Communication Training Intervention for Large B-Cell Lymphoma

    Recruiting
    • Lymphoma, B-Cell
    • +5 more
    • Hematolo-GIST Training
    • Participants Appointment
    • New York, New York
    • +2 more
    Jul 3, 2023

    Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

    Recruiting
    • Burkitt Lymphoma
    • +2 more
    • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital of Sun Yat-sen University
    Sep 25, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

    Recruiting
    • Diffuse Large B-cell Lymphoma Recurrent
    • Diffuse Large B Cell Lymphoma Refractory
    • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Oct 12, 2023

    Elastography and Treatment of Lymphoma

    Not yet recruiting
    • Elastography
    • Lymphoma
      • (no location specified)
      Jul 23, 2023

      Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

      Withdrawn
      • Diffuse Large B Cell Lymphoma
      • +4 more
      • (no location specified)
      Jun 28, 2023

      ASCT Versus Chemotherapy as First-Line Consolidation Therapy

      Completed
      • T-cell Lymphoma Adults
      • consolidation with ASCT
      • (no location specified)
      Nov 25, 2023

      Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

      Not yet recruiting
      • Follicular Lymphoma
      • +2 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 13, 2023

      Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

      Recruiting
      • Peripheral T Cell Lymphoma
      • +2 more
      • Chidamide combined with Duvillisib
      • Xiamen, Fujian, China
        The First Affiliated Hosptial of Xiamen University
      Nov 28, 2023

      Patient Perspectives in Mantle Cell Lymphoma Clinical Research

      Not yet recruiting
      • Mantle Cell Lymphoma
        • San Francisco, California
          Power Life Sciences
        Sep 15, 2023

        Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

        Not yet recruiting
        • Follicular Lymphoma
        • New York, New York
          Weill Cornell Medicine/NewYork-Presbyterian Hospital
        Aug 8, 2023

        Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
        • (no location specified)
        Sep 5, 2023

        Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

        Recruiting
        • Relapsed/Refractory Follicular Lymphoma
        • Marginal Zone Lymphoma (MZL)
        • Chiang Mai, Thailand
          Chiang Mai University
        Nov 20, 2023

        Lymphoma Trial (Fatigue Reduction Diet, General Health Curriculum)

        Not yet recruiting
        • Lymphoma
        • Fatigue Reduction Diet
        • General Health Curriculum
        • (no location specified)
        Sep 14, 2023

        Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

        Not yet recruiting
        • Relapsed Non-Hodgkin Lymphoma
        • +6 more
        • (no location specified)
        Apr 12, 2023